Integrity BMS    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

William O’Neill, MD, Performs First Transcatheter Triscuspid Valve Replacement in the United States
New Outcomes Study for Ticagrelor (BRILINTA™) to Examine Longer-term Treatment for Post- ACS Patients
Boston Scientific and ASAHI INTECC to Collaborate on Cardiac Intervention Devices
CE Mark Approved for Boston Scientific’s Agent PTCA Balloon
Transluminal’s Velox CD Vascular Closure Device Approved in Europe






 

 

Gathering Momentum for Percutaneous Mitral Valve

Percutaneous mitral valve repair is being increasingly recognized as an acceptable treatment strategy in high-risk patients with severe MR. The European Sentinel Registry of 628 patients has shown high procedural success (95.4%), low in-hospital mortality (2.9%), and 1-year mortality of 15.3%.

For more, click here

 

 

 

The Prognostic Value of Lipoprotein

Lipoprotein (a) has been shown to be a risk factor for CVD. A study of 826 individuals has shown that lipoprotein (a) can serve as a predictor of CVD outcomes and may improve CVD risk prediction.

For more, click here

 

 

 

Alcohol & the Risk of AAA

The role of alcohol in the pathogenesis of abdominal aortic aneurysm (AAA) is uncertain. A Swedish study has indicated that moderate alcohol consumption, particularly wine and beer, is associated with a lower hazard of AAA.

For more, click here

 

 

 

Race, Age & Mortality Following MI

Black patients are less likely to receive evidence-based therapy following MI. Analysis of data from the CRUSADE registry has indicated that, as compared to whites, older black patients had lower initial mortality following an acute MI but this did not persist during long-term follow-up.

For more, click here

 

<
||
>





























CRT2013
Untitled Document
 
Angio in Patients without Stress Test
- Mouin S. Abdallah, MS, et al.
Complementary role of percutaneous and surgical circulatory support in cardiogenic shock: Introduction and objectives
- Holger Thiele, MD
How to Solve a Bifurcation Puzzle?: Anatomical, Physiological, and Clinical Relevance of Bifurcation Lesions
- Bon-Kwon Woo, MD, PhD
The Heart Team: Challenges and Strategies for Success
- David J. Cohen, MD, MSc
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study: (the cardiac-RESCUE program)
- Sylvain Beurtheret, MD, et al.

Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD

 Click here to visit the WEBEX archives


Aortic-Valve Stenosis: From Patients at Risk to Severe Valve Obstruction.
C Otto & B Prendergast
NEJM 2014; 371:744-756
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a): Prospective 15-Year Outcomes in the Bruneck Study.
P Willeit, et al.
JACC 2014; 64:851-860
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry.
K Mayer, et al.
JACC 2014; 64:863-871
Percutaneous Mitral Valve Edge-to-Edge Repair: In-Hospital Results and 1-Year Follow-Up of 628 Patients of the 2011–2012 Pilot European Sentinel Registry.
G Nickenig, et al.
JACC 2014; 64:875-884
Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults: A Randomized Clinical Trial.
N Rigotti, et al.
JAMA 2014; 312:719-728
Alcohol Consumption, Specific Alcoholic Beverages, and Abdominal Aortic Aneurysm.
O Stackelberg, et al.
Circ 2014; 130:646-652
Age-Specific Exercise Capacity Threshold for Mortality Risk Assessment in Male Veterans.
P Kokkinos, et al.
Circ 2014; 130:653-658
Differences in Short-Term Versus Long-Term Outcomes of Older Black Versus White Patients With Myocardial Infarction: Findings From the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE).
R Mathews, et al.
Circ 2014; 130:659-667
Prevalence, Characteristics, and Predictors of Early Termination of Cardiovascular Clinical Trials Due to Low Recruitment: Insights From the ClinicalTrials.gov Registry.
S Bernardez-Pereira, et al.
AHJ 2014; 168:213-219
Comparison of the Use of Hemodynamic Support in Patients ≥80 Years Versus Patients <80 Years During High-Risk Percutaneous Coronary Interventions (From the Multicenter PROTECT II Randomized Study).
A Pershad, et al.
AJC 2014; 114:657-664




Poll Archives




Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD
The RESOLUTE Program: today and tomorrow
Sigmund Silber, MD, PhD
RESOLUTE International Trial
F-J. Neumann, MD, et al.
Primary Results Following Percutaneous Coronary Intervention with the 38mm Resolute Zotarolimus-eluting Stent
Shirish Hiremath, MD, et al.
Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Small (less or equal to 2.5 mm) Vessels
Ronald Caputo, MD



8/20/2014
Transluminal’s Velox CD Vascular Closure Device Approved in Europe

8/20/2014
Thoratec Begins HeartMate PHP CE Mark Trial

8/20/2014
William O’Neill, MD, Performs First Transcatheter Triscuspid Valve Replacement in the United States

8/20/2014
Boston Scientific and ASAHI INTECC to Collaborate on Cardiac Intervention Devices

8/20/2014
Medicare NCD Expands Access to Abbott’s MitraClip System

8/20/2014
Medtronic and ACIST Enter Into Co-Promotion of Next-Generation FFR and IVUS Technologies in the USA

8/20/2014
Boston Scientific Receives FDA Approval for REBEL Platinum Chromium Coronary Stent System

8/8/2014
CE Mark Approved for Boston Scientific’s Agent PTCA Balloon

8/8/2014
Siemens to Sell Hospital Information Systems Business to Cerner

8/8/2014
St. Jude Medical’s CardioMems HF System Receives CMS Approval for New Technology Add-On Payment

7/31/2014
Avinger Begins VISION Trial of the Pantheris Catheter

7/31/2014
Enrollment Completed in Pivotal ROADSTER Trial for Silk Road’s Enroute CAS Device

7/31/2014
BIOLUX 4EVER Will Evaluate Combined Treatment With Biotronik’s Pulsar-18 Stent and Passeo-18 Lux Balloon for SFA Disease

7/31/2014
Teleflex’s Arrow-Clark VectorFlow Chronic Hemodialysis Catheter Receives FDA Clearance

7/30/2014
Biotronik Completes Enrollment in SFA Arm of the BIOFLEX-I Study

7/30/2014
Boston Scientific Launches Polaris Imaging System

7/25/2014
FDA Approves Boston Scientific’s Bare-Metal Rebel PtCr Coronary Stent System

7/25/2014
Boston Scientific Launches POLARIS™ Imaging System
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2013 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2014, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb